Detalhe da pesquisa
1.
Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting Myelopoiesis.
Circ Res
; 127(7): 877-892, 2020 09 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32564710
2.
Alpha cell receptor for advanced glycation end products associate with glucagon expression in type 1 diabetes.
Sci Rep
; 13(1): 12948, 2023 08 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37558746
3.
Soluble RAGE Prevents Type 1 Diabetes Expanding Functional Regulatory T Cells.
Diabetes
; 71(9): 1994-2008, 2022 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35713929
4.
Short Duration Alagebrium Chloride Therapy Prediabetes Does Not Inhibit Progression to Autoimmune Diabetes in an Experimental Model.
Metabolites
; 11(7)2021 Jun 28.
Artigo
Inglês
| MEDLINE | ID: mdl-34203471
5.
Kidney disease risk factors do not explain impacts of low dietary protein on kidney function and structure.
iScience
; 24(11): 103308, 2021 Nov 19.
Artigo
Inglês
| MEDLINE | ID: mdl-34820603
6.
Advanced glycation end products as predictors of renal function in youth with type 1 diabetes.
Sci Rep
; 11(1): 9422, 2021 05 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33941808
7.
T-Cell Expression and Release of Kidney Injury Molecule-1 in Response to Glucose Variations Initiates Kidney Injury in Early Diabetes.
Diabetes
; 70(8): 1754-1766, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34285121
8.
Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 Diabetes.
Nutrients
; 12(10)2020 Sep 24.
Artigo
Inglês
| MEDLINE | ID: mdl-32987824
9.
Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes.
Sci Rep
; 7(1): 15190, 2017 11 09.
Artigo
Inglês
| MEDLINE | ID: mdl-29123192
10.
Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice.
Sci Rep
; 6: 26428, 2016 05 26.
Artigo
Inglês
| MEDLINE | ID: mdl-27226136
11.
Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice.
Sci Rep
; 6: 28124, 2016 07 07.
Artigo
Inglês
| MEDLINE | ID: mdl-27389496